Rebecca Taub
Director · MADRIGAL PHARMACEUTICALS, INC.
- 2025
- Jun 18, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rebecca Taub files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William John Sibold - $10.48M in MDGL purchases and sales in the last 12 months
- Kenneth Bate - $8.03M in MDGL purchases and sales in the last 12 months
- Richard S. Levy - $7.36M in MDGL purchases and sales in the last 12 months
- Mardi Dier - $3.77M in MDGL purchases and sales in the last 12 months
- Carole Huntsman - $1.71M in MDGL purchases and sales in the last 12 months
- David Soergel - $952K in MDGL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rebecca Taub?
Rebecca Taub is a corporate insider, tracked as Director of MADRIGAL PHARMACEUTICALS, INC. (MDGL). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Rebecca Taub last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 7 filings going back to 2025.
Has Rebecca Taub been buying or selling stock?
Recorded transactions: 0 open-market purchases and 25 open-market sales ($28.77M) across all tracked filings.
